Publications

5891 Results

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

Authors
MM Dias;J-P Pignon;CS Karapetis;V Boige;B Glimelius;DM Kweekel;PN Lara;Laurent-Puig;E Martinez-Balibrea;D Paez;CJA Punt;M Redman;G Toffoli;M Wadelius;RA McKinnon;MJ Sorich
Journal / Conference
Pharmacogenomics Journal 214(5):424-431;
Year
2014
Research Committee(s)
Lung
PMID
PMID24709690
PMC
pending
Study Number(s)
S0124

Association between BMI at treatment initiation and cancer survival across multiple SWOG trials

Authors
H Greenlee;J Unger;M Leblanc;D Hershman
Journal / Conference
AACR Research International Conference on Frontiers on Cancer Research Prevention (Sept 28-Oct 1, 2014, New Orleans, LA; poster
Year
2014
Research Committee(s)
Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, and Sarcoma
Study Number(s)
S0003, S0033, S0221, SWOG-8507, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8706, SWOG-8736 (INT-0093), SWOG-8795 (INT-0094) (EST-1888), SWOG-8814, SWOG-8897, SWOG-8949, SWOG-9012, SWOG-9031, SWOG-9308, SWOG-9333, SWOG-9346, SWOG-9420, SWOG-9500, SWOG-9509, S9701, S9916

S0800: Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim with or without Bevacizumab in Treating Women with Inflammatory or Locally Advanced Breast Cancer (NCI CDR0000636131)

Authors
Z Nahleh;W Barlow;D Hayes;A Schott;J Gralow;E Perez;W Sikov;S Chennuru;H Mirshahidi;S Vidito;D Lew;L Pusztai;R Livingston;G Hortobagyi
Journal / Conference
San Antonio Breast Cancer Symposium, abstr. [P3-11-16]; poster presentation;
Year
2014
Research Committee(s)
Breast
Study Number(s)
S0800

Leveraging population admixture to explain missing heritability of complex traits

Authors
N Zaitlen;B Pasaniuc;S Sankararaman;G Bhatia;J Zhang;A Gusev;T Young;A Tandon;S Pollack;B Vilhjalmsson;TL Assimes;SI Berndt;WJ Blot;S Chanock;N Francedschini;P Goodman;J He;A Hennis;A Hsing;S Ingles;W Isaacs;R Kittles;EA Klein;L Lange;B Nemesure;N Patterson;D Reich;B Rybicki;J Stanford;V Stevens;S Strom;E Whitsel;J Witte;J Xu;C Haiman;C Kooperberg;D Stram;A Reiner;H Tang;A Price
Journal / Conference
Nature Genetics 46(12):1356-1362;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID25383972
PMC
PMC4244251
Study Number(s)
S0000

A randomized phase II study of azacitidine combined with lenalidomide or with vorinostat vs. azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML): North American Intergroup study SWOG S1117

Authors
M Sekeres;M Othus;AF List;O Odenike;RM Stone;S Gore;M Litzow;R Buckstein;M Velasco;R Gaur;E Attallah;EC Attar;FR Appelbaum;HP Erba
Journal / Conference
Blood 124(21):LBA-5; American Society for Hematology (December 6-9, 2014, San Francisco, CA), LBA, oral;
Year
2014
Research Committee(s)
Leukemia
Study Number(s)
S1117

Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): analysis of the SOFT trial

Authors
P Francis;M Regan;G Fleming;I Lang;E Ciruelos;M Bellet;H Bonnefoi;M Climent;L Pavesi;H Burstein;S Martino;NE Davidson;CE Geyer;B Walley;RE Coleman;P Kerbrat;M Rabaglio-Poretti;AS Coates;A Goldhirsch;RD Gelber
Journal / Conference
San Antonio Breast Cancer Symposium Annual Meeting (December 9-13, 2014, San Antonio, TX),abstr. [S3-08], oral presentation;
Year
2014
Research Committee(s)
Breast

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

Authors
AA Al Olama;Z Kote-Jarai;DV Conti;F Schumacher;Y Han;S Benloch;DJ Hazelett;Z Wang;E Saunders;D Leongamornlert;S Lindstrom;S Jugurnauth-Little;T Dadaev;M Tymrakiewicz;DO Stram;X Sheng;LC Pooler;K Park;L Xia;J Tyrer;LN Kolonel;L Le Marchand;RN Hoover;MJ Machiela;M Yeager;L Burdette;C Chung;A Hutchinson;K Yu;C Goh;M Ahmed;K Govindasami;M Guy;TL Tammela;A Auvinen;T Wahlfors;J Schleutker;T Visakorpi;KA Keinonen;J Xu;M Aly;J Donovan;RC Travis;TJ Key;A Siddiq;F Canzian;KT Khaw;A Takahashi;M Kubo;P Pharoah;N Pashayan;M Weischer;BG Nordestgaard;SF Nielsen;P Klarskov;MA Roder;P Iversen;SN Thibodeau;SK McDonnell;DJ Schaid;JL Stanford;S Kolb;S Holt;B Knudsen;AH Coll;SM Gapstur;WR Diver;VL Stevens;C Maier;M Luedeke;K Herkommer;AE Rinckleb;SS Strom;C Pettaway;ED Yeboah;Y Tettey;RB Biritwum;A Adjei;E Tay;A Truelove;S Niwa;A Chokkalingam;L Cannon-Albright;C Cybulski;Wokolorczyk;W Kluzniak;J Park;T Sellers;HY Lin;WB Isaacs;AW Partin;H Brenner;A Dieffenbach;C Stegmaier;C Chen;EL Giovannucci;J Ma;M Stampfer;KL Penney
Journal / Conference
Nature Genetics 46(10):1103-1109;
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID25217961
PMC
PMC4383163
Study Number(s)
S0000

Normal young-old men: Results from PREADVISE

Authors
E Abner;R Kryscio;A Caban-Holt;F Schmitt
Journal / Conference
The Journal of Prevention of Alzheimer’s Disease 1(3): 259-60, 2014; Clinical Trials Conf. on Alzheimer’s Disease (Nov. 20-22, 2014, Phil., PA), poster
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000A

Lower quality of life scores at baseline are associated with an increased risk of future cognitive impairment: Results from PREADVISE

Authors
R Kryscio;A Abner;A Caban-Holt;FA Schmitt
Journal / Conference
The Journal of Prevention of Alzheimer’s Disease, 1(3):283; 2014;Clinical Trials Conf. on Alzheimer’s Disease (November 20-22, 2014, Phil., PA), poster
Year
2014
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000A

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

Authors
EA Perez;EH Romond;VJ Suman;JH Jeong;G Sledge;CE Geyer;S Martino;P Rastogi;J Gralow;S Swain;E Winer;G Colon-Otero;NE Davidson;E Mamounas;JA Jujewski;N Wolmark
Journal / Conference
Journal of Clinical Oncology Nov 20;32(33):3744-3752
Year
2014
Research Committee(s)
Breast
PMID
PMID25332249
PMC
PMC4226805
Study Number(s)
N9831